secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2021-12-08T23:59:59+00:00
Accession:  0001021771-21-000099
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies enters CFO employment agreement with $175K salary, stock option grant
--------------------------------------------------------------------------------

- CFO Robert E. Kristal employment agreement effective Nov 4, 2021, term through Nov 4, 2022.
- Annual salary of $175,000; eligible for discretionary bonus up to 30% of salary.
- Granted 10-year option to purchase 10,490 shares at $13.50 per share.
- Severance: if terminated without cause or resigns for good reason, receives lesser of remaining salary or 25% of current salary, paid over 3 months.
- One-year post-employment non-compete covering stem-cell therapy businesses in the US.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177121000099/0001021771-21-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177121000099/form8kdtd120321.htm
  HTML page:      https://secwatch.observer/filing/0001021771-21-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer